Rovalpituzumab Tesirine (SC16LD6.5) in Recurrent Small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Donald Strickland, MD
SCRI Innovations
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- Florida Cancer Specialists
Sarasota, Florida, United States
- University of Chicago Medical Center
Chicago, Illinois, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Tennessee Oncology
Nashville, Tennessee, United States
- University of Texas Md Anderson Cancer Center
Houston, Texas, United States
- Blue Ridge Cancer Care
Roanoke, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2013
- Primary completion
- 28 Nov 2016
- Completion
- 28 Nov 2016
- Last update posted
- 9 Aug 2018
- Registered enrollment
- 82
- Registry id
- NCT01901653
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.